Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott MacDonald

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Harm Reduction Journal|April 14, 2023
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crisesKaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
The International Journal on Drug Policy|December 31, 2022
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, et al.
Journal of Substance Abuse Treatment|June 7, 2021
A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use researchKirsten Marchand, Heather Palis, Daphne Guh, et al.
Journal of Addiction Medicine|February 8, 2020
Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment ToolHeather Palis, Kirsten Marchand, Scott Beaumont, et al.
JMIR Medical Informatics|April 17, 2026
Quality of Clinical Notes Created by Ambient Listening Generative AI: Pragmatic Prospective Pilot StudySandra L Taylor, Melissa Jost, Scott MacDonald, et al.
Patient Preference and Adherence|December 30, 2022
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot StudySophia Dobischok, Rebecca K Metcalfe, Elizabeth Angela Matzinger, et al.
Acta Cytologica|June 30, 2020
Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® PrefixationSi Kei Lou, Hyang Mi Ko, Tomonari Kinoshita, et al.
BMC Health Services Research|May 26, 2023
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative studyEugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, et al.
Addiction (Abingdon, England)|June 15, 2006
Acute alcohol use and the risk of non-fatal injury in sixteen countriesGuilherme Borges, Cheryl J Cherpitel, Ricardo Orozco, et al.
Annals of Internal Medicine|September 23, 2024
Quality Indicators for Pain in Adults: A Review of Performance Measures by the American College of PhysiciansAmir Qaseem, Karen Campos, Scott MacDonald, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Harm Reduction Journal|April 14, 2023
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crisesKaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
The International Journal on Drug Policy|December 31, 2022
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, et al.
Journal of Substance Abuse Treatment|June 7, 2021
A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use researchKirsten Marchand, Heather Palis, Daphne Guh, et al.
Journal of Addiction Medicine|February 8, 2020
Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment ToolHeather Palis, Kirsten Marchand, Scott Beaumont, et al.
JMIR Medical Informatics|April 17, 2026
Quality of Clinical Notes Created by Ambient Listening Generative AI: Pragmatic Prospective Pilot StudySandra L Taylor, Melissa Jost, Scott MacDonald, et al.
Patient Preference and Adherence|December 30, 2022
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot StudySophia Dobischok, Rebecca K Metcalfe, Elizabeth Angela Matzinger, et al.
Acta Cytologica|June 30, 2020
Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® PrefixationSi Kei Lou, Hyang Mi Ko, Tomonari Kinoshita, et al.
BMC Health Services Research|May 26, 2023
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative studyEugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, et al.
Addiction (Abingdon, England)|June 15, 2006
Acute alcohol use and the risk of non-fatal injury in sixteen countriesGuilherme Borges, Cheryl J Cherpitel, Ricardo Orozco, et al.
Annals of Internal Medicine|September 23, 2024
Quality Indicators for Pain in Adults: A Review of Performance Measures by the American College of PhysiciansAmir Qaseem, Karen Campos, Scott MacDonald, et al.
Pageof 14